Clinical Trials Directory

Trials / Completed

CompletedNCT05982444

Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH)

Long Term Post-operative Effectiveness and Morbidity of Rezum Therapy for Benign Prostatic Hyperplasia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
86 (actual)
Sponsor
Helwan University · Academic / Other
Sex
Male
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to assess the effectiveness and morbidity of water vapor thermal therapy (Rezūm therapy) for benign prostatic hyperplasia (BPH). Data will be collected and analyzed from patients treated by Rezūm and followed up for 4 years prior to evaluating clinical outcomes.

Detailed description

The investigators will conduct a retrospective study evaluating patients treated with water vapor thermal therapy (Rezūm therapy) for BPH and followed up for4 years. The primary objectives are to assess the long-term effectiveness and morbidity rates associated with the procedure. Data collected will include urinary symptom scores, sexual function, and any treatment-related complications.

Conditions

Interventions

TypeNameDescription
PROCEDUREwater vapor thermal therapy (Rezum) for prostateall patients underwent rezum therapy for bph are evaluated for its effectiveness for long period

Timeline

Start date
2021-03-01
Primary completion
2025-03-01
Completion
2025-05-01
First posted
2023-08-08
Last updated
2025-06-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05982444. Inclusion in this directory is not an endorsement.